Swallowing alcohol-based hand sanitiser can kill, warns an analysis of two such deaths identified in coroners’ reports, and published in…
Home »
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…
Analysis: Talc-based cosmetics test positive for asbestos
Laboratory tests of talc-based cosmetics products, commissioned by the Environmental Working Group, found asbestos—a deadly human carcinogen for which there…
Statistical analysis weighs the risks in the fight against COVID-19
Western Sydney University researchers have used advanced statistical analysis to better understand how countries are impacted by COVID-19. A funded…
Breast cancer deaths hit a record LOW, analysis reveals
Breast cancer deaths hit a record LOW in Britain as analysis reveals 130,000 deaths from the killer disease have been…
The clinical utility of network analysis is still uncertain
A paper published in the current issue of Psychotherapy and Psychosomatics, provides a careful analysis of network analysis, a new…
Superimposition of eye fundus images for longitudinal analysis from large public health databases
We have introduced an efficient method to superimpose eye fundus images from persons with diabetes screened over many years for…
Use of image analysis to ID HER2 status in breast cancer outlined
(HealthDay)—Recommendations have been developed to improve accuracy, precision, and reproducibility in the interpretation of human epidermal growth factor receptor 2…